The FDA is working to develop and approve safe and effective therapeutic COVID-19 treatments. The FDA established CTAP, the Coronavirus Treatment Acceleration Program, to expedite the development of COVID-19 treatments. A handful of treatments including Convalescent Plasma have been approved for emergency use authorization (EUA), but only one, Remdesivir, is approved for treatment.
Choose a treatment, Convalescent Plasma or Remdesivir, research it and provide a summary of the treatment.
Is it effective? Based on your findings discuss your thoughts about its use, safety, and effectiveness thus far.
